Current Studies

Condition	Additional Trial Information
Anticoagulant Reversal	Efficacy and Safety Study of BERIPLEX^® P/N Compared With Plasma in Patients on Anticoagulant Therapy Who Require Emergency Surgery or Invasive Intervention > Learn More
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)	Study of Efficacy and Safety of Privigen in Subjects with Chronic Inflammatory Demyelinating Polyneuropathy > Learn More
Congenital Fibrinogen Deficiency	Fibrinogen Concentrate (Human) − Efficacy and Safety Study > Learn More
Emphysema Caused by API Deficiency	Study of Zemaira i.v. Administration in Subjects Who Completed a 2-Year Controlled Study With This Treatment and Have Emphysema Due to alpha1 -Proteinase Inhibitor Deficiency. > Learn More
Emphysema Caused by API Deficiency	Zemaira in Subjects With Emphysema Due to Alpha1-Proteinase Inhibitor (API) Deficiency > Learn More
Factor XIII Deficiency	A Study of Factor XIII Concentrate in Subjects With Congenital Factor XIII Deficiency > Learn More
Hemophilia A	Study of Biostate^® in Children with Hemophilia A > Learn More
Hemophilia B	Safety and Pharmacokinetic Study of a Recombinant Coagulation Factor IX Albumin Fusion Protein in Subjects with Hemophilia B > Learn More
Primary Immune Deficiency	Safety Study of Subcutaneous Ig NextGen 16% in Patients With Primary Immunodeficiency > Learn More
Von Willebrand Disease	Study of a Plasma-Derived Von Willebrand Factor/Factor VIII Concentrate (vWF/FVIII), Biostate^®, in Subjects With Von Willebrand Disease > Learn More
Von Willebrand Disease	Study of Biostate^® in Children with Von Willebrand Disease > Learn More
Von Willebrand Disease	Extension Study of Biostate^® in Subjects with Von Willebrand Disease > Learn More

> Learn how to participate in clinical trials
> Learn more about our products

Choose country

Current Studies